Sanchez-Aranguren, Lissette Carolina
Ahmad, Shakil
Dias, Irundika H. K.
Alzahrani, Faisal A.
Rezai, Homira
Wang, Keqing
Ahmed, Asif
Funding for this research was provided by:
Medical Research Council (G0700288, G0700288)
King Abdulaziz University (KEP-42-130-39, KEP-42-130-39)
British Heart Foundation (FS/15/72/31676, FS/15/72/31676)
Article History
Received: 11 May 2020
Accepted: 26 August 2020
First Online: 25 September 2020
Competing interests
: L.S.A., I.H.K.D., H.R. and F.A.A. have no conflict of interest. S.A., K.W. and A.A. hold patents on methods to treat preeclampsia. A.A. is the Founder and Executive Chairman of Mirzyme Therapeutics and the majority shareholder.